DK109784C - Fremgangsmåde til fremstilling af naphthoxypropanolaminderivater eller syreadditionssalte deraf. - Google Patents

Fremgangsmåde til fremstilling af naphthoxypropanolaminderivater eller syreadditionssalte deraf.

Info

Publication number
DK109784C
DK109784C DK486665AA DK486665A DK109784C DK 109784 C DK109784 C DK 109784C DK 486665A A DK486665A A DK 486665AA DK 486665 A DK486665 A DK 486665A DK 109784 C DK109784 C DK 109784C
Authority
DK
Denmark
Prior art keywords
naphthoxypropanolamine
derivatives
preparation
acid addition
addition salts
Prior art date
Application number
DK486665AA
Other languages
English (en)
Original Assignee
Ici Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Ltd filed Critical Ici Ltd
Application granted granted Critical
Publication of DK109784C publication Critical patent/DK109784C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/58Preparation of carboxylic acid halides
    • C07C51/60Preparation of carboxylic acid halides by conversion of carboxylic acids or their anhydrides or esters, lactones, salts into halides with the same carboxylic acid part
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/58Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C07C59/66Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK486665AA 1962-11-23 1963-11-20 Fremgangsmåde til fremstilling af naphthoxypropanolaminderivater eller syreadditionssalte deraf. DK109784C (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB44357/62A GB994918A (en) 1962-11-23 1962-11-23 Naphthoxy-substituted alkanolamines

Publications (1)

Publication Number Publication Date
DK109784C true DK109784C (da) 1968-07-01

Family

ID=10432900

Family Applications (4)

Application Number Title Priority Date Filing Date
DK542563AA DK109992C (da) 1962-11-23 1963-11-20 Fremgangsmåde til fremstilling af naphthoxypropanolaminderivater eller syreadditionssalte deraf.
DK486665AA DK109784C (da) 1962-11-23 1963-11-20 Fremgangsmåde til fremstilling af naphthoxypropanolaminderivater eller syreadditionssalte deraf.
DK486565AA DK111204B (da) 1962-11-23 1965-09-22 Fremgangsmåde til fremstilling af naphthoxypropanolaminderivater eller syreadditionssalte deraf.
DK486465AA DK111203B (da) 1962-11-23 1965-09-22 Fremgangsmåde til fremstilling af naphthoxypropanolaminderivater eller syreadditionssalte deraf.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK542563AA DK109992C (da) 1962-11-23 1963-11-20 Fremgangsmåde til fremstilling af naphthoxypropanolaminderivater eller syreadditionssalte deraf.

Family Applications After (2)

Application Number Title Priority Date Filing Date
DK486565AA DK111204B (da) 1962-11-23 1965-09-22 Fremgangsmåde til fremstilling af naphthoxypropanolaminderivater eller syreadditionssalte deraf.
DK486465AA DK111203B (da) 1962-11-23 1965-09-22 Fremgangsmåde til fremstilling af naphthoxypropanolaminderivater eller syreadditionssalte deraf.

Country Status (13)

Country Link
US (2) US3337628A (da)
AT (3) AT244949B (da)
BE (1) BE640312A (da)
BR (1) BR6354781D0 (da)
CH (1) CH493463A (da)
CY (1) CY339A (da)
DE (1) DE1493847A1 (da)
DK (4) DK109992C (da)
ES (1) ES293736A1 (da)
FI (1) FI40904B (da)
GB (1) GB994918A (da)
MY (1) MY6600009A (da)
NL (1) NL300886A (da)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6504268A (da) * 1965-04-03 1966-10-04
US3466325A (en) * 1965-04-30 1969-09-09 Haessle Ab 1-(ortho-alkenyl phenoxy) - 2-hydroxy-3-isopropylaminopropanes and the salts thereof
US3959359A (en) * 1968-01-23 1976-05-25 Laboratoires Laroche Navarron Phenoxyalkylamines, process for their preparation and therapeutical composition containing same
US3534084A (en) * 1968-10-16 1970-10-13 Squibb & Sons Inc Adamantylamino-naphthyloxypropanols and related compounds
SE372762B (da) * 1969-05-21 1975-01-13 Haessle Ab
US3961072A (en) * 1969-12-17 1976-06-01 Pfizer Inc. Phenoxypropanolamine therapeutic agents
US3996284A (en) * 1971-03-23 1976-12-07 Wijbe Thomas Nauta Naphthyl and tetrahydronaphthyl di-ethers
BE790165A (fr) * 1971-12-14 1973-02-15 Parke Davis & Co Nouveaux aminoalcanols et procede pour les preparer
DE2354444A1 (de) * 1973-10-31 1975-05-07 Merck Patent Gmbh Biphenylylaether und verfahren zu ihrer herstellung
US4051186A (en) * 1974-06-20 1977-09-27 The Regents Of The University Of California Amino-propranolol
US4379167A (en) * 1974-10-25 1983-04-05 A. H. Robins Company, Inc. 1-Aryloxy-4-amino-2-butanols and the pharmaceutical use thereof
DE2505423A1 (de) * 1975-02-08 1976-08-19 Merck Patent Gmbh Biphenylylaether und verfahren zu ihrer herstellung
US4071552A (en) * 1976-05-19 1978-01-31 Ayerst Mckenna And Harrison Ltd. Aryloxy aminobutanols, their preparation and use thereof
US4201866A (en) * 1977-01-17 1980-05-06 American Home Products Corporation O-Hemi-succinate of propranolol
US4463190A (en) * 1977-07-05 1984-07-31 A. H. Robins Company, Inc. 1-Aryloxy-4-amino-2-butanols
DE2962112D1 (en) * 1978-02-08 1982-03-25 Ici Plc Alkanolamine derivatives, process for their preparation and pharmaceutical compositions containing them
US4241177A (en) * 1978-08-28 1980-12-23 Syva Company Propanolol antigen conjugates and antibodies
US4585785A (en) * 1979-01-09 1986-04-29 A. H. Robins Company, Inc. Cis and trans-3-aryloxy-4-hydroxypyrrolidines used as anti-arrhythmics
RO71464A2 (ro) * 1979-02-23 1981-05-15 Intreprinderea De Medicamente,Ro Procedeu pentru fabricarea 1-(1-naftoxi) 3-izopropilamino-2-propanolului
US4284648A (en) * 1979-08-03 1981-08-18 The University Of Kentucky Research Foundation Nasal administration of propranolol
DE3068678D1 (en) * 1979-08-10 1984-08-30 Sandoz Ag 3-aminopropoxyaryl derivatives, their preparation and pharmaceutical compositions containing them
US4376125A (en) * 1980-11-05 1983-03-08 University Of Virginia Alumni Patents Foundation Aminobenzlpropranolol and pharmaceutical preparation thereof
US4405642A (en) * 1980-11-28 1983-09-20 American Hospital Supply Corporation Method for treatment or prophylaxis of cardiac disorders
US4321398A (en) * 1981-05-07 1982-03-23 Mead Johnson & Company Thienyl and benzothienyl-tertiary butylaminophenoxypropanols
US4402974A (en) * 1981-06-23 1983-09-06 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
FR2521136A1 (fr) * 1982-02-05 1983-08-12 Synthelabo Derives de piperidine, leur preparation et leur application en therapeutique
IT1212552B (it) * 1982-10-20 1989-11-30 Italo Britannica L Manet Ti H Alcanolaminossi derivati di 3,4-diidro-2h-1.4-benzotiazin-3-one, loro procedimento di produzione e loro utilizzazione farmaceutica
US4517188A (en) * 1983-05-09 1985-05-14 Mead Johnson & Company 1-Pyrimidinyloxy-3-hetaryl-alkylamino-2-propanols
NZ208337A (en) * 1983-06-10 1988-10-28 Bristol Myers Co 2-(2-hydroxy-3-((2-(ar-hydroxy-1h-aminopropoxy-yl)ethyl benzonitriles and pharmaceutical compositions
DE3330005A1 (de) * 1983-08-19 1985-02-28 Wolfgang Dr. Graz Lindner Weinsaeuremonoester von optisch aktiven alkanolaminen, verfahren zu ihrer herstellung und ihre verwendung
US4593039A (en) * 1984-04-02 1986-06-03 Merck & Co., Inc. 1-aryloxy-3-(substituted aminoalkylamino)-2-propanols
US4897355A (en) 1985-01-07 1990-01-30 Syntex (U.S.A.) Inc. N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US5545412A (en) * 1985-01-07 1996-08-13 Syntex (U.S.A.) Inc. N-[1, (1-1)-dialkyloxy]-and N-[1, (1-1)-dialkenyloxy]-alk-1-yl-n,n,n-tetrasubstituted ammonium lipids and uses therefor
JPS61210063A (ja) * 1985-03-14 1986-09-18 Mitsubishi Chem Ind Ltd アリ−ルスルホン類
US5095151A (en) * 1985-05-21 1992-03-10 American Home Products Corporation Preparation of propranolol hydrochloride macrocrystals
US4888354A (en) * 1987-12-21 1989-12-19 Theratech, Inc. Skin penetration enhancement using free base and acid addition salt combinations of active agents
US5013761A (en) * 1988-06-03 1991-05-07 Eli Lilly And Company Serotonin antagonists
US5387613A (en) * 1993-07-23 1995-02-07 Ribogene, Inc. Treatment of tachyarrhythmias of supraventricular origin
CA2134038C (en) * 1994-06-16 1997-06-03 David Taiwai Wong Potentiation of drug response
EP0714663A3 (en) 1994-11-28 1997-01-15 Lilly Co Eli Potentiation of drug responses by serotonin 1A receptor antagonists
ATE192042T1 (de) * 1995-08-16 2000-05-15 Lilly Co Eli Potenzierung von serotonin-wirkstoffresponz
US5776985A (en) * 1995-11-16 1998-07-07 The George Washington University Fluorinated propranolol and related methods
US5967613A (en) * 1997-08-11 1999-10-19 Piccard Corporation Wheelchair support and attachment system
GB0023467D0 (en) * 2000-09-25 2000-11-08 Btg Int Ltd Amine compounds
US7022342B2 (en) 2002-03-28 2006-04-04 Andrx Corporation, Inc. Controlled release oral dosage form of beta-adrenergic blocking agents
AP2005003232A0 (en) 2002-08-19 2005-03-31 Pfizer Prod Inc Combination therapy for hyperproliferative diseases.
US20050037063A1 (en) * 2003-07-21 2005-02-17 Bolton Anthony E. Combined therapies
US20060063803A1 (en) * 2004-09-23 2006-03-23 Pfizer Inc 4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds
US20060182806A1 (en) * 2004-11-08 2006-08-17 Mintong Guo Extended-release propranolol composition
AP2764A (en) * 2005-01-31 2013-09-30 Mylan Lab Inc Hydroxylated nebivolol metabolites
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
CN101663262B (zh) 2006-12-01 2014-03-26 百时美施贵宝公司 用于治疗动脉粥样硬化和心血管疾病的作为cetp抑制剂的n-(3-苄基)-2,2-(二苯基)-丙-1胺衍生物
CN104189906A (zh) * 2007-01-29 2014-12-10 V生命科学技术有限公司 用于治疗糖尿病并发症的药用组合物
WO2008112287A1 (en) * 2007-03-12 2008-09-18 Nektar Therapeutics Oligomer-beta blocker conjugates
MX2015014666A (es) 2013-04-17 2016-03-01 Pfizer Derivados de n-piperidin-3-ilbenzamida para tratar enfermedades cardiovasculares.
EP2959904A1 (en) 2014-06-27 2015-12-30 Institut De Recerca Contra La Leucemia Josep Carreras Methods for treating, diagnosing and prognosing a haematological malignancy
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
WO2018161039A1 (en) 2017-03-03 2018-09-07 Synovo Gmbh Novel anti-infective and anti-inflammatory compounds
US11382875B2 (en) 2017-04-07 2022-07-12 Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center Methods and compositions for modulating β-amyloid/α7-nAChR interactions
EP3911648A4 (en) 2019-01-18 2022-10-26 Astrazeneca AB PCSK9 INHIBITORS AND METHODS OF USE THEREOF

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB622297A (en) * 1946-12-06 1949-04-29 British Drug Houses Ltd Improvements in or relating to the preparation of basic ethers
US3033640A (en) * 1954-06-16 1962-05-08 Saul & Co Incorporation of an organic basic compound into cellulose acetate materials
FR1198123A (fr) * 1958-06-02 1959-12-04 Rech S Biolog Soc D Procédé de préparation d'aryloxy-amino-alcools et de leurs dérivés (sels, esters, ammoniums quaternaires) et produits obtenus par la mise en oeuvre de ce procédé
GB1023214A (en) * 1962-12-17 1966-03-23 Ici Ltd Carbocyclic hydroxyamines
GB1069343A (en) * 1963-09-10 1967-05-17 Ici Ltd Propanolamine derivatives

Also Published As

Publication number Publication date
DK111204B (da) 1968-07-01
BR6354781D0 (pt) 1973-07-12
BE640312A (da) 1964-05-22
MY6600009A (en) 1966-12-31
AT244948B (de) 1966-02-10
DK111203B (da) 1968-07-01
CY339A (en) 1966-01-12
AT246734B (de) 1966-05-10
US3520919A (en) 1970-07-21
CH493463A (de) 1970-07-15
DK109992C (da) 1968-08-19
ES293736A1 (es) 1964-03-01
AT244949B (de) 1966-02-10
GB994918A (en) 1965-06-10
DE1493847A1 (de) 1971-07-22
NL300886A (da)
US3337628A (en) 1967-08-22
FI40904B (da) 1969-03-31

Similar Documents

Publication Publication Date Title
DK109992C (da) Fremgangsmåde til fremstilling af naphthoxypropanolaminderivater eller syreadditionssalte deraf.
DK119165C (da) Fremgangsmåde til fremstilling af benzimidazolonderivater eller syreadditionssalte heraf.
DK105476C (da) Fremgangsmåde til fremstilling af sekundære 2-aminomethylbenzodioxanderivater eller syreadditionssalte deraf.
DK115330B (da) Fremgangsmåde til fremstilling af pyridodioxepinderivater eller syreadditionssalte deraf.
DK114840B (da) Fremgangsmåde til fremstilling af diaralkylaminer eller syreadditionssalte heraf.
DK109779C (da) Fremgangsmåde til fremstilling af 3-aminopyrazinamidoguanidinforbindelser eller syreadditionssalte heraf.
DK111894B (da) Fremgangsmåde til fremstilling af diphenylalkylaminer eller syreadditionssalte deraf.
DK105024C (da) Fremgangsmåde til fremstilling af piperidylidenthiaxanthenderivater eller syreadditionssalte heraf.
DK109925C (da) Fremgangsmåde til fremstilling af N-substituerede 1-phenyl-2-aminopropaner eller syreadditionssalte heraf.
DK107807C (da) Fremgangsmåde til fremstilling af quinolinderivater eller syreadditionssalte deraf.
DK103511C (da) Fremgangsmåde til fremstilling af carbostyrilderivater eller syreadditionssalte deraf.
DK108528C (da) Fremgangsmåde til fremstilling af diphenylpropylaminderivater eller syreadditionssalte deraf.
DK105028C (da) Fremgangsmåde til fremstilling N-benzyl-piperazinderivater eller syreadditionssalte heraf.
DK105340C (da) Fremgangsmåde til fremstilling af quinolinderivater eller syreadditionssalte deraf.
DK104171C (da) Fremgangsmåde til fremstilling af morfantridinderivater eller syreadditionssalte heraf.
DK104466C (da) Fremgangsmåde til fremstilling af 1-phenyl-2-alkylaminoethanolderivater eller syreadditionssalte deraf.
DK103077C (da) Fremgangsmåde til fremstilling af 4-hydroxyphenyl-4-carbalkoxy-piperidinderivater eller syreadditionssalte deraf.
DK108498C (da) Fremgangsmåde til fremstilling af imidazolderivater eller syreadditionssalte deraf.
DK109676C (da) Fremgangsmåde til fremstilling af primære alkylphenylalkylaminer eller syreadditionssalte deraf.
DK106378C (da) Fremgangsmåde til fremstilling af N-substituerede 1-phenyl-2-aminoalkaner eller syreadditionssalte heraf.
DK104134C (da) Fremgangsmåde til fremstilling af piperideinoalkylguanidinderivater eller syreadditionssalte heraf.
DK108790C (da) Fremgangsmåde til fremstilling af tetraethoxy-benzyl-tetrahydroisoquinolinderivater eller syreadditionssalte deraf.
DK107418C (da) Fremgangsmåde til fremstilling af phenoxyalkylaminoguanidiner eller syreadditionssalte heraf.
DK100557C (da) Fremgangsmåde til fremstilling af α-pyrrolidinovalerophenoner eller syreadditionssalte deraf.
DK107225C (da) Fremgangsmåde til fremstilling af bis-aralkylaminoalkyl-cyclohexaner eller syreadditionssalte heraf.